NEUPOGEN Amgen 48 mio U/0.5ml ser pré 5 pce
7680510352085
CH-51035
L03AA02
06.07.3.
Reimbursement limitations:
NEUPOGEN
Administration au cours des chimiothérapies fortement myélotoxiques permettant d'espérer une évolution positive chez les patients …
1 / 3
google
Details
- Product number
- 5103507
- CPT
- -
- Packaging group
- 5 x 0.5 mL
- Unit
- Spritze(n)
- Composition
- filgrastimum 48 Mio. U., acidum aceticum glaciale, natrii hydroxidi solutio 18% m/m corresp. natrium 15.9 µg, polysorbatum 80, sorbitolum 25 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.
Articles (1)
Neupogen Amgen 48, Injektionslösung in einer Fertigspritze
Injektionslösung
5 x 0.5 mL
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
15.9 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
25.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 540.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1996
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 51035
- Drug name
- Neupogen Amgen, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L03AA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 11/10/1991
- Authorization expiration date
- 31/12/9999
- IT number
- 06.07.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NEUPOGEN Amgen 48 mio U/0.5ml ser pré 5 pce
- Description (DE)
- NEUPOGEN Amgen 48 Mio E/0.5ml Fertspr 5 Stk
- Market launch
- 27/11/1998
- Narcotic (BTM)
- No